Clinical Trials Logo

Clinical Trial Summary

Schwannomas are mainly benign tumors, which develop mainly in the skull or in the cervical region. Retroperitoneal location is rare, since it represents between 0.5 and 5% of scwhanomas. The malignant retroperitoneal form is, however, more common than in other locations. Retroperitoneal schwannoma is often discovered during the exploration of unexplained lumbo-pelvic pain, or in the face of compression of nearby organs. Abdominopelvic CT and magnetic resonance imaging are essential to characterize the mass and verify its extension. The precise diagnosis is based on the pathological examination of the part, and complete surgical excision is the standard treatment. Acquiring the surgical techniques and skills necessary to carry out these types of procedures is essential to providing optimal patient care.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06313411
Study type Observational
Source University Hospital, Strasbourg, France
Contact Emilie FALLER, MD
Phone 33 3 88 12 63 87
Email emilie.faller@chru-strasbourg.fr
Status Recruiting
Phase
Start date November 23, 2022
Completion date April 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05722314 - ENDOMED: Evaluation of the Evolution of Endometriosis Lesions on Imaging Under Medical Treatment
Completed NCT04296760 - Rectal Water-contrast Transvaginal Ultrasonography Versus Sonovaginography for the Diagnosis of Posterior Deep Pelvic Endometriosis
Recruiting NCT05362838 - Conventional Laparoscopy Versus Robotic Surgery for Pain Relief in Patients With Deep Infiltrating Endometriosis N/A